Centene (NYSE:CNC) Updates FY 2025 Earnings Guidance

Centene (NYSE:CNCGet Free Report) issued an update on its FY 2025 earnings guidance on Tuesday morning. The company provided earnings per share guidance of 7.250- for the period, compared to the consensus earnings per share estimate of 7.250. The company issued revenue guidance of -.

Centene Stock Performance

Shares of NYSE:CNC traded down $2.22 on Tuesday, hitting $62.60. 2,957,227 shares of the company were exchanged, compared to its average volume of 4,008,076. Centene has a one year low of $55.03 and a one year high of $81.42. The firm has a market capitalization of $31.60 billion, a price-to-earnings ratio of 10.85, a PEG ratio of 0.85 and a beta of 0.45. The company has a debt-to-equity ratio of 0.64, a quick ratio of 1.10 and a current ratio of 1.10. The company’s 50 day moving average price is $61.17 and its two-hundred day moving average price is $67.14.

Centene (NYSE:CNCGet Free Report) last announced its quarterly earnings data on Tuesday, February 4th. The company reported $0.80 earnings per share for the quarter, beating the consensus estimate of $0.44 by $0.36. Centene had a return on equity of 13.32% and a net margin of 1.90%. During the same period in the previous year, the business posted $0.45 earnings per share. Research analysts expect that Centene will post 6.82 earnings per share for the current year.

Wall Street Analyst Weigh In

Several analysts have recently issued reports on the company. Barclays upped their price objective on Centene from $91.00 to $93.00 and gave the stock an “overweight” rating in a report on Friday, December 13th. Jefferies Financial Group downgraded shares of Centene from a “hold” rating to an “underperform” rating and reduced their price target for the company from $68.00 to $52.00 in a research report on Tuesday, December 10th. Sanford C. Bernstein cut their target price on shares of Centene from $96.00 to $88.00 and set an “outperform” rating on the stock in a research note on Wednesday, October 30th. Cantor Fitzgerald reissued an “overweight” rating and set a $90.00 target price on shares of Centene in a report on Wednesday, December 11th. Finally, StockNews.com raised shares of Centene from a “buy” rating to a “strong-buy” rating in a research note on Monday, January 27th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating, nine have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $81.31.

Check Out Our Latest Research Report on Centene

Insider Buying and Selling

In related news, CEO Sarah London acquired 4,117 shares of the stock in a transaction that occurred on Friday, November 8th. The shares were acquired at an average price of $60.80 per share, for a total transaction of $250,313.60. Following the completion of the purchase, the chief executive officer now directly owns 667,229 shares of the company’s stock, valued at $40,567,523.20. The trade was a 0.62 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CFO Andrew Lynn Asher acquired 17,200 shares of the stock in a transaction that occurred on Wednesday, November 13th. The shares were bought at an average cost of $58.14 per share, for a total transaction of $1,000,008.00. Following the completion of the transaction, the chief financial officer now directly owns 486,847 shares of the company’s stock, valued at $28,305,284.58. This represents a 3.66 % increase in their position. The disclosure for this purchase can be found here. Over the last ninety days, insiders bought 45,010 shares of company stock valued at $2,660,276. 0.29% of the stock is owned by insiders.

About Centene

(Get Free Report)

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.

Further Reading

Earnings History and Estimates for Centene (NYSE:CNC)

Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.